Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - Sex differences and associations with morbidity and medication use.

Toepfer S, Bolbrinker J, König M, Steinhagen-Thiessen E, Kreutz R, Demuth I.

PLoS One. 2019 Dec 30;14(12):e0226511. doi: 10.1371/journal.pone.0226511. eCollection 2019.

2.

[Pharmacology of non-opioid analgesics].

Schneider J, Kreutz R, Bolbrinker J.

Schmerz. 2019 Apr;33(2):165-179. doi: 10.1007/s00482-018-0339-x. German.

PMID:
30535850
3.
4.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Aug;96(8):765-775. doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

PMID:
29934777
5.

Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.

Algharably EAH, Bolbrinker J, Lezius S, Reibis R, Wegscheider K, Völler H, Kreutz R.

J Hypertens. 2017 Oct;35(10):2053-2058. doi: 10.1097/HJH.0000000000001432.

PMID:
28598953
6.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
7.

European guidelines on lifestyle changes for management of hypertension : Awareness and implementation of recommendations among German and European physicians.

Bolbrinker J, Zaidi Touis L, Gohlke H, Weisser B, Kreutz R.

Herz. 2018 Jun;43(4):352-358. doi: 10.1007/s00059-017-4575-0. Epub 2017 May 22.

PMID:
28534177
8.

Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.

Abdel-Hady Algharably E, Beige J, Kreutz R, Bolbrinker J.

Pharmacogenomics J. 2018 Apr;18(2):227-231. doi: 10.1038/tpj.2017.14. Epub 2017 Apr 18.

PMID:
28418009
9.

Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.

Rekers NV, Flaig TM, Mallat MJK, Spruyt-Gerritse MJ, Zandbergen M, Anholts JDH, Bajema IM, Clahsen-van Groningen MC, Yang J, de Fijter JW, Claas FHJ, Brakemeier S, Lachmann N, Kreutz R, de Heer E, Budde K, Bolbrinker J, Eikmans M.

Transplantation. 2017 Sep;101(9):2017-2025. doi: 10.1097/TP.0000000000001584.

PMID:
27926596
10.

Tissue Factor: A Conventional or Alternative Target in Cancer Therapy.

Eisenreich A, Bolbrinker J, Leppert U.

Clin Chem. 2016 Apr;62(4):563-70. doi: 10.1373/clinchem.2015.241521. Epub 2016 Feb 19. Review.

PMID:
26896447
11.

Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E114. doi: 10.3390/ijms17010114.

12.

[Diclofenac up2date - Part 2: The use in specific groups of patients].

Bushuven S, Heise D, Bolbrinker J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 Dec;49(11-12):670-9; quiz 680. doi: 10.1055/s-0040-100121. Epub 2015 Jan 9. Review. German.

PMID:
25575232
13.

[Diclofenac up2date - Part 1: Pharmacology and comparison with other drugs].

Bushuven S, Heise D, Bolbrinker J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 Oct;49(10):588-98; quiz 599. doi: 10.1055/s-0034-1395170. Epub 2014 Oct 28. Review. German.

PMID:
25350096
14.

Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.

Douros A, Schlemm L, Bolbrinker J, Ebinger M, Kreutz R.

Thromb Haemost. 2014 Aug;112(2):419-20. doi: 10.1160/TH14-02-0104. Epub 2014 Apr 3. No abstract available.

PMID:
24695752
15.

Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.

Karle J, Bolbrinker J, Vogl S, Kreutz R, Denkert C, Eucker J, Wischnewsky M, Possinger K, Regierer AC.

Breast Cancer Res Treat. 2013 Jun;139(2):553-60. doi: 10.1007/s10549-013-2565-3. Epub 2013 May 18.

PMID:
23686417
16.

Genetics of melatonin receptor type 2 is associated with left ventricular function in hypertensive patients treated according to guidelines.

Huber M, Treszl A, Reibis R, Teichmann C, Zergibel I, Bolbrinker J, Scholze J, Wegscheider K, Völler H, Kreutz R.

Eur J Intern Med. 2013 Oct;24(7):650-5. doi: 10.1016/j.ejim.2013.03.015. Epub 2013 Apr 21.

PMID:
23611530
17.

Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma.

Huber M, Kölzsch M, Stahlmann R, Hofmann W, Bolbrinker J, Dräger D, Kreutz R.

Drugs Aging. 2013 Jan;30(1):31-8. doi: 10.1007/s40266-012-0036-x.

PMID:
23184270
18.

Anticontractile Effect of Perivascular Adipose Tissue and Leptin are Reduced in Hypertension.

Gálvez-Prieto B, Somoza B, Gil-Ortega M, García-Prieto CF, de Las Heras AI, González MC, Arribas S, Aranguez I, Bolbrinker J, Kreutz R, Ruiz-Gayo M, Fernández-Alfonso MS.

Front Pharmacol. 2012 Jun 5;3:103. doi: 10.3389/fphar.2012.00103. eCollection 2012.

19.

Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia.

Huber M, Kölzsch M, Rapp MA, Wulff I, Kalinowski S, Bolbrinker J, Hofmann W, Scholze J, Dräger D, Kreutz R.

Pharmacopsychiatry. 2012 Jul;45(5):182-8. doi: 10.1055/s-0031-1301285. Epub 2012 Mar 19.

PMID:
22430201
20.

Genetic variants implicated in telomere length associated with left ventricular function in patients with hypertension and cardiac organ damage.

Huber M, Treszl A, Wehland M, Winther I, Zergibel I, Reibis R, Bolbrinker J, Stoll M, Schönfelder G, Wegscheider K, Völler H, Kreutz R.

J Mol Med (Berl). 2012 Sep;90(9):1059-67.

PMID:
22314626
21.

CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele.

Bolbrinker J, Seeberg S, Schostak M, Kempkensteffen C, Baelde H, de Heer E, Kreutz R.

Drug Metab Dispos. 2012 Apr;40(4):639-41. doi: 10.1124/dmd.111.042648. Epub 2012 Jan 3.

PMID:
22214815
22.

[Potentially inappropriate medication for the elderly: adaptation and evaluation of a French consensus list].

Kölzsch M, Bolbrinker J, Huber M, Kreutz R.

Med Monatsschr Pharm. 2010 Aug;33(8):295-302. German.

PMID:
21189649
23.

[Prescribing of antihypertensive drugs to elderly residents of nursing homes in Germany].

Kölzsch M, Bolbrinker J, Dräger D, Scholze J, Huber M, Kreutz R.

Dtsch Med Wochenschr. 2010 Dec;135(48):2400-5. doi: 10.1055/s-0030-1269407. Epub 2010 Nov 24. German.

PMID:
21108153
24.

Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome.

Huber M, Heiduschka P, Ziemssen F, Bolbrinker J, Kreutz R.

Hypertens Res. 2011 Jan;34(1):103-12. doi: 10.1038/hr.2010.168. Epub 2010 Oct 7.

PMID:
20927114
25.

Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men.

Bolbrinker J, Beige J, Huber M, Sharma AM, Thomas A, Deter HC, Kreutz R.

J Hypertens. 2011 Jan;29(1):56-61. doi: 10.1097/HJH.0b013e32833f5de5.

PMID:
20852447
26.

Prescribing of inappropriate medication in nursing home residents in Germany according to a French consensus list: a cross-sectional cohort study.

Kölzsch M, Kopke K, Fischer T, Hofmann W, Kuhnert R, Bolbrinker J, Kuhlmey A, Dräger D, Kreutz R.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):12-9. doi: 10.1002/pds.2005.

PMID:
20848559
27.

Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients.

Huber M, Völler H, Jakob S, Reibis R, Do V, Bolbrinker J, Zergibel I, Schmieder RE, Treszl A, Wegscheider K, Kreutz R.

J Hypertens. 2010 Jun;28(6):1221-9. doi: 10.1097/HJH.0b013e32833aa356.

PMID:
20467270
28.

Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27.

Kamilic J, Hamming I, Kreutz R, Bolbrinker J, Siems WE, Nassar I, Sluimer JC, Walther T, Navis GJ, van Goor H.

Hypertens Res. 2010 Feb;33(2):123-8. doi: 10.1038/hr.2009.191. Epub 2009 Nov 20.

PMID:
19927150
29.

The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum.

Marnitz S, Schmittel A, Bolbrinker J, Schmidt FP, Fons G, Kalache K, Schneider A, Köhler C.

Fertil Steril. 2009 Nov;92(5):1748.e1-4. doi: 10.1016/j.fertnstert.2009.07.1000. Epub 2009 Sep 18.

PMID:
19765705
30.

Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.

Bolbrinker J, Huber M, Scholze J, Kreutz R.

Fundam Clin Pharmacol. 2009 Dec;23(6):767-74. doi: 10.1111/j.1472-8206.2009.00720.x. Epub 2009 Jul 31.

PMID:
19659504
31.

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R.

BMC Neurol. 2009 Jun 28;9:26. doi: 10.1186/1471-2377-9-26.

32.

[Antihypertensive drug treatment and renal function in geriatric emergency patients].

Bolbrinker J, Schedensack G, Kölzsch M, Breckwoldt J, Arntz HR, Kreutz R.

Dtsch Med Wochenschr. 2009 Apr;134(16):802-6. doi: 10.1055/s-0029-1220233. Epub 2009 Apr 7. German.

PMID:
19353463
33.

Genetic analysis of salt-sensitive hypertension in Dahl rats reveals a link between cardiac fibrosis and high cholesterol.

Wendt N, Schulz A, Qadri F, Bolbrinker J, Kossmehl P, Winkler K, Stoll M, Vetter R, Kreutz R.

Cardiovasc Res. 2009 Feb 15;81(3):618-26. doi: 10.1093/cvr/cvn263. Epub 2008 Sep 29.

PMID:
18824493
34.

Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue.

Gálvez-Prieto B, Bolbrinker J, Stucchi P, de Las Heras AI, Merino B, Arribas S, Ruiz-Gayo M, Huber M, Wehland M, Kreutz R, Fernandez-Alfonso MS.

J Endocrinol. 2008 Apr;197(1):55-64. doi: 10.1677/JOE-07-0284.

PMID:
18372232
35.

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

Kreutz R, Bolbrinker J, van der Sman-de Beer F, Boeschoten EW, Dekker FW, Kain S, Martus P, Sietmann A, Friedrichs F, Stoll M, Offermann G, Beige J.

Pharmacogenomics J. 2008 Dec;8(6):416-22. doi: 10.1038/sj.tpj.6500488. Epub 2008 Jan 8.

PMID:
18180803
36.

Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.

de Borst MH, Diks SH, Bolbrinker J, Schellings MW, van Dalen MB, Peppelenbosch MP, Kreutz R, Pinto YM, Navis G, van Goor H.

Am J Physiol Renal Physiol. 2007 Jul;293(1):F428-37. Epub 2007 Apr 11.

37.

Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects.

Kreutz R, Bolbrinker J, Huber M.

Clin Drug Investig. 2006;26(1):29-34.

PMID:
17163232
38.

Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.

Huber M, Bolbrinker J, Kreutz R.

Clin Exp Hypertens. 2006 Oct;28(7):631-43.

PMID:
17060062
39.

No association of the CYP3A5*1 allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy.

Lieb W, Bolbrinker J, Döring A, Hense HW, Erdmann J, Schunkert H, Kreutz R.

Clin Sci (Lond). 2006 Dec;111(6):365-72.

PMID:
16822233
40.

The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population.

Kreutz R, Zuurman M, Kain S, Bolbrinker J, de Jong PE, Navis G.

Pharmacogenet Genomics. 2005 Dec;15(12):831-7.

PMID:
16272955
41.

Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.

Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.

J Pharmacol Exp Ther. 2006 Jan;316(1):8-16. Epub 2005 Sep 15.

PMID:
16166267
42.

Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites.

Funke-Kaiser H, Thomas A, Bremer J, Kovacevic SD, Scheuch K, Bolbrinker J, Theis S, Lemmer J, Zimmermann A, Zollmann FS, Herrmann SM, Paul M, Orzechowski HD.

J Hypertens. 2003 Nov;21(11):2111-24.

PMID:
14597855
43.

Characterization of the c-specific promoter of the gene encoding human endothelin-converting enzyme-1 (ECE-1).

Funke-Kaiser H, Bolbrinker J, Theis S, Lemmer J, Richter CM, Paul M, Orzechowski HD.

FEBS Lett. 2000 Jan 28;466(2-3):310-6.

Supplemental Content

Loading ...
Support Center